CASI Pharmaceuticals
CASI
#10986
Rank
NZ$7.21 M
Marketcap
NZ$0.35
Share price
0.00%
Change (1 day)
-91.04%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.68. In 2024 the company made an earnings per share (EPS) of NZ-$4.33 a decrease over its 2023 EPS that were of NZ-$3.42.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.657.44%
2024NZ-$4.3326.73%
2023NZ-$3.42-32.89%
2022NZ-$5.0911.9%
2021NZ-$4.55-38.44%
2020NZ-$7.39-8.96%
2019NZ-$8.1250%
2018NZ-$5.4177.78%
2017NZ-$3.045.88%
2016NZ-$2.87-22.73%
2015NZ-$3.72-76.09%
2014NZ-$15.56318.18%
2013NZ-$3.72-71.79%
2012NZ-$13.1965.96%
2011NZ-$7.95-50%
2010NZ-$15.90-18.97%
2009NZ-$19.62-63.64%
2008NZ-$53.953.57%
2007NZ-$52.09-60.56%
2006NZ-$132.0897.22%
2005NZ-$66.97-2.7%
2004NZ-$68.83-45.59%
2003NZ-$126.49-61.8%
2002NZ-$331.12-25.52%
2001NZ-$444.59-21.38%
2000NZ-$565.5013.86%
1999NZ-$496.68149.53%
1998NZ-$199.0498.15%
1997NZ-$100.4510.2%
1996NZ-$91.15